Paasa Logo
Fusion Antibodies plc logo
FABLSEMarket openCloses 4:30pm UK

Fusion Antibodies plc

£0.12Last updated
-£0.00 (2.92%)Past day
Timezone

Fusion Antibodies plc (LSE: FAB) is trading at £0.12, about ₹15 at today's GBP/INR rate, as of 30 Sep 2026, 3:00 AM ET, down 2.92% today. Indian residents can buy Fusion Antibodies from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:£0.12
Previous close:£0.12
Volume:9.00K

Today's low

£0.12

Today's high

£0.12

52 week low

£0.09

52 week high

£0.20

FAB opened at £0.12, closed previously at £0.12, and has traded between £0.09 and £0.20 over the past 52 weeks.

About

Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.

Country
GB
CEO
Adrian Robert Kinkaid
Exchange listed on
LSE
Industry
Biotechnology
Base currency
GBP
Full Time Employees
27
Sector
Healthcare
IPO date
18/12/2017

Key statistics

Avg. volume

371.37K

Market cap

£14.58M

P/E Ratio

-11.77

Price-to-sales ratio

6.91

Enterprise value

£13.70M

Free cash flow yield

-8.11%

Debt-to-equity ratio

0.20

Return on equity

-70.84%

ROIC

-99.85%

Beta

1.24

Dividend yield

0.00%

Last dividend

£0.00

Financial overview

Revenue

£2.11M

Earnings per share

-£0.01

Free cash flow

-£1.17M

Net profit margin

-54.45%

Gross margin

52.32%

EBITDA

-£1.85M

Revenue growth

7.38%

Similar securities

This is not an investment recommendation

How to buy Fusion Antibodies from India

Indian residents can buy Fusion Antibodies shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.

  3. Search for Fusion Antibodies and place an order

    Find Fusion Antibodies by name or by its ticker, FAB, and choose an order type. Fusion Antibodies trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Fusion Antibodies position in GBP and INR. Fusion Antibodies pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Fusion Antibodies from India

Trading and taxes when buying Fusion Antibodies from India

Trading and limits

Trading hours
8:00 am – 4:30 pm UK
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneFusion Antibodies does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Transaction tax
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
Estate or inheritance tax
May applyShares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Fusion Antibodies stock?

Yes. Fusion Antibodies (FAB) has been listed on the London Stock Exchange since 2017, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Fusion Antibodies share cost in rupees?

One Fusion Antibodies share is £0.12 — about ₹15 at a GBP/INR rate of 127.06 on 29 Sep 2026. Both the Fusion Antibodies price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Fusion Antibodies from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Fusion Antibodies shares taxed in India?

Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Fusion Antibodies price. Paasa issues a capital-gains statement for your return.

Does Fusion Antibodies pay a dividend?

No. Fusion Antibodies does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Fusion Antibodies from India?

The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Fusion Antibodies shares held from India?

Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. It applies to your overall holdings in that jurisdiction rather than to any one position.

Are there transaction taxes when buying Fusion Antibodies?

The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.

Do I have to declare Fusion Antibodies shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Fusion Antibodies holding, its cost and its closing value.

How do I sell Fusion Antibodies and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.